GILEAD SCIENCES, INC.

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GILEAD SCIENCES, INC.'s trades of Arcus Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-20 2025-02-18
B Purchase
22,804 +36.2%
141.28
US$2,019,753 		22,804 +36.2% 141.28 US$2,019,753
2024-12-23 2024-12-19
B Purchase
22,762 +43.9%
205.71
US$3,099,282 		22,762 +43.9% 205.71 US$3,099,282
2024-12-19 2024-12-18
B Purchase
56,126 -3.7%
242.82
US$122,646 		56,126 -3.7% 242.82 US$122,646
2024-04-03 2024-04-02
B Purchase
485,250 +7.1%
0.76
US$368,790 		485,250 +7.1% 0.76 US$368,790
2024-02-13 2024-02-12
B Purchase
910,000 +28.3%
22.00
US$20,020,000 		910,000 +28.3% 22.00 US$20,020,000
2024-01-31 2024-01-29
B Purchase
15,238,095 +102.8%
21.00
US$319,999,995 		15,238,095 +102.8% 21.00 US$319,999,995
2023-06-28 2023-06-27
B Purchase
2,930,870 +21.4%
3.75
US$10,990,762 		2,930,870 +21.4% 3.75 US$10,990,762
2021-02-02 2021-01-31
B Purchase
5,650,000 +68.4%
39.00
US$220,350,000 		5,650,000 +68.4% 39.00 US$220,350,000